Theres a great risk of muscle loss and malnutrition They can interfere with the absorption of other meds, including psychiatric meds Some people wont lose any weight at all Most people will regain weight after they discontinue use (as is the case with any diet) Theres limited long term research and a whole bunch of misinformation They can alter taste perception and decrease the enjoyment of eating So we know they can help with diabetes, theres a long list of risks and more we dont know, and at the same time some people have found GLP-1s offer the potential to re-connect with internal signals and eventually help build body trust
However, these results must be contextualised carefully: Phase 2 trials are not powered to detect cardiovascular outcomes such as myocardial infarction, stroke, or cardiovascular mortality No dedicated cardiovascular outcome trial (CVOT) data exist for retatrutide such trials are required before definitive conclusions about cardiovascular benefit or risk can be drawn
The committee concluded that the current evidence called for further action, including updated consumer and clinical safety warnings
As weight-loss treatments continue to evolve, two medications are leading the conversation: Retatrutide and Mounjaro (tirzepatide)
Inquire about how to get Retatrutide when it becomes available, ensuring continuity in care and long-term success
Clinical Grade Research Peptides Delivered UK Wide Buy Retatrutide, Tirzepatide, and Semaglutide with absolute confidence
